Open Access

Challenge of hypertension management in 2022

Event: ESC Congress 2022
Topic: Hypertension
Session type: Satellite Symposium
Sponsored by Servier
Date: 27 August 2022
Time: 15:30 - 16:15

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

6 presentations in this session

Introduction.

Speaker: Professor G. Mancia (Milan, IT)
Thumbnail

Are ACE inhibitors still the cornerstone of cardiovascular protection?

Speaker: Professor R. Ferrari (Ferrara, IT)
Thumbnail

Can we individualize treatment of hypertensive patients with single-pill combination therapies?

Speaker: Professor N. Poulter (London, GB)
Thumbnail

What should be the optimal quadri-therapy in clinical practice?

Speaker: Professor R. Kreutz (Berlin, DE)
Thumbnail

Q&A session.

Speaker: Professor R. Kreutz (Berlin, DE)
Speaker: Professor N. Poulter (London, GB)
Speaker: Professor R. Ferrari (Ferrara, IT)
Speaker: Professor G. Mancia (Milan, IT)
Thumbnail

Conclusion.

Speaker: Professor R. Kreutz (Berlin, DE)
Thumbnail

9 speakers from this session

Professor Giuseppe Mancia

University of Milan Bicocca, Milan (Italy)
23 presentations
0 follower

Professor Roberto Ferrari

University of Ferrara, Ferrara (Italy)
14 presentations
2 followers

Professor Neil Poulter

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
23 presentations
0 follower

Professor Reinhold Kreutz

Charité - University Medicine Berlin, Berlin (Germany)
8 presentations
0 follower

Professor Reinhold Kreutz

Charité - University Medicine Berlin, Berlin (Germany)
8 presentations
0 follower

Professor Neil Poulter

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
23 presentations
0 follower

Professor Roberto Ferrari

University of Ferrara, Ferrara (Italy)
14 presentations
2 followers

Professor Giuseppe Mancia

University of Milan Bicocca, Milan (Italy)
23 presentations
0 follower

Professor Reinhold Kreutz

Charité - University Medicine Berlin, Berlin (Germany)
8 presentations
0 follower

This platform is supported by

logo Novo Nordisk